AtriCure
ATRC
79 hedge funds and large institutions have $170M invested in AtriCure in 2013 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 39 increasing their positions, 12 reducing their positions, and 6 closing their positions.
225% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 12
133% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 6
16% more capital invested
Capital invested by funds: $146M → $170M (+$24M)
11% more funds holding
Funds holding: 71 → 79 (+8)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.55M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$4.26M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
+$1.76M |
| 4 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$1.36M |
| 5 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$1.12M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MRM
Michael R. Murphy
|
-$7.48M |
| 2 |
DM
Deerfield Management
New York
|
-$5.99M |
| 3 |
CAM
Cortina Asset Management
Milwaukee,
Wisconsin
|
-$1.64M |
| 4 |
BC
Broadfin Capital
New York
|
-$1.13M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$953K |
ATRC Hedge Fund Activity: Q3 2013 in Review
79 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q3 2013, worth a combined $170M — up 16% from $146M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new ATRC positions and 6 closed out — a net gain of 8 holders — while 39 added to existing stakes and 12 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $4.55M. The largest seller was Michael R. Murphy, exiting entirely with an estimated $7.48M sold.
- 79 institutional investors held AtriCure (ATRC) as of Q3 2013, up from 71 in Q2 2013.
- Funds reported $170M of AtriCure stock for Q3 2013, up 16% quarter-over-quarter.
- 14 funds opened new AtriCure positions in Q3 2013 and 6 closed out, a net change of +8 holders.
- The largest AtriCure buyer in Q3 2013 was Fidelity Investments, an estimated $4.55M added.
- The largest AtriCure seller in Q3 2013 was Michael R. Murphy, an estimated $7.48M sold.
Based on aggregated 13F filings for Q3 2013.